News | Nuclear Imaging | September 27, 2018

Technology and Radionucleotide Development Will Fuel Mobile Gamma Camera Adoption

New high-sensitivity PET tracers, trends toward solid state and dual-head gamma cameras expected to push total market revenue past $75 million by 2029

Technology and Radionucleotide Development Will Fuel Mobile Gamma Camera Adoption

September 27, 2018 — Advancements in healthcare technology, particularly in the surgery category, have led to an increasing adoption of gamma cameras. Further, the numerous developments in radionucleotides are anticipated to favor the adoption of solid state cameras and mobile gamma cameras. These findings are presented in a new research study on the global mobile gamma cameras market by Future Market Insights (FMI).

Single photon emission computed tomography (SPECT) is currently the biggest application of gamma cameras given the low cost, large suite of radioisotopes and expanded use cases. According to FMI, however, positron emission tomography (PET) is anticipated to witness the fastest growth in terms of adoption, owing to the greater special resolution and sensitivity brought about by the use of positron emitting radioisotopes that provide more energy, contrast and special resolution.

According to FMI analysis, the high costs of PET as compared to SPECT are expected to be negated in the wake of development of high sensitivity and selective tracers. FMI predicts a growth rate of 4.8 percent for the mobile gamma cameras market during the 10-year period from 2018 to 2028. Revenue from the sales of mobile gamma cameras is estimated to reach $75.2 million by the end of 2028, up from $47.2 million in 2018.

Being a high-value, low-volume market, technology plays a vital role in the mobile gamma cameras market, where the technologically advanced products are priced at a premium. The development of solid state sensors is slowly replacing the photomultiplier tube and this represents the biggest technological development in the market followed by miniaturization.

A notable trend being observed in the market is the shift towards dual-head gamma cameras. Single-head mobile gamma cameras have certain inherent disadvantages such as slow speed and lower density count, leading to the inability to perform different types of tests. This has resulted in an elevated demand for multiple-head cameras. Dual-head cameras increase total counts per stop, resulting in relatively lesser scan time and better image quality, leading to enhanced accuracy in diagnosis.

Further, according to FMI, the latest mobile gamma cameras come with newer and better functionalities. Owing to advances in electronic components and software, modern mobile gamma cameras include advanced reconstruction algorithms and periodic updates that help boost scan speeds and image correction parameters. Advanced gamma camera software also facilitates more personalized patient scans by tracking patient activity and performing appropriate scans.

The full market intelligence outlook from FMI can be downloaded here.

For more information: www.futuremarketinsights.com

Related Content

Feature | Nuclear Imaging | By Staff of the American Society of Nuclear Cardiology (ASNC)

A year after COVID-19 turned the world upside down, the American Society of Nuclear Cardiology (ASNC) asked members how ...

Home June 02, 2021
Home
News | Nuclear Imaging

April 1, 2021 – The ability to measure myocardial blood flow (MBF) as part of myocardial perfusion imaging (MPI) is one ...

Home April 01, 2021
Home
News | Nuclear Imaging

December 4, 2020 — Spectrum Dynamics Medical, Inc., has received Canadian Medical Device License from Health Canada for ...

Home December 04, 2020
Home
News | Nuclear Imaging

September 30, 2020 — Siemens Healthineers has introduced a new version of its c.cam dedicated cardiac nuclear medicine ...

Home October 07, 2020
Home
Feature | Nuclear Imaging | Dave Fornell, Editor

There were a few key takeaways from the American Society of Nuclear Cardiology (ASNC) 2019 annual meeting in September ...

Home November 22, 2019
Home
Videos | Nuclear Imaging

Rob Beanlands, M.D., FASNC, 2019 American Society of Nuclear Cardiology (ASNC) president, shares a couple trends he sees ...

Home November 07, 2019
Home
Videos | Nuclear Imaging

Robert C. Hendel, M.D., explains some of the new cardiac radiotracers in the pipeline that were discussed in sessions at ...

Home November 06, 2019
Home
Feature | Nuclear Imaging | Christopher A. Hanson M.D., and Jamieson M. Bourque M.D., MHS

Cardiac amyloidosis is a highly morbid and underdiagnosed infiltrative cardiomyopathy that is characterized by the ...

Home July 22, 2019
Home
Videos | Nuclear Imaging

Raza Alvi, M.D., a research fellow in radiology at Massachusetts General Hospital, has been involved in a study of a ...

Home March 22, 2019
Home
News | Nuclear Imaging

November 15, 2018 — GE Healthcare announced it is recalling its Millennium Nuclear Medicine Systems due to an incident ...

Home November 15, 2018
Home
Subscribe Now